The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Clinical & Manufacturing

4D Pharma Clinical Update on MRx0518 Oncology Programmes
Clinical & Manufacturing

4D Pharma Clinical Update on MRx0518 Oncology Programmes

MAY 1, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD

APR 11, 2019
The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms
Clinical & Manufacturing

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

APR 3, 2019
New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students
Clinical & Manufacturing

New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students

APR 1, 2019
Clinical Study Results Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations
Clinical & Manufacturing

Clinical Study Results Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations

MAR 25, 2019
SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials
Clinical & Manufacturing

SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials

MAR 11, 2019
Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI
Clinical & Manufacturing

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

FEB 28, 2019
The Human Microbiome: A Global Overview of Clinical Trials Activity
Clinical & Manufacturing

The Human Microbiome: A Global Overview of Clinical Trials Activity

FEB 5, 2019
Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma
Clinical & Manufacturing

Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma

JAN 29, 2019
Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH
Clinical & Manufacturing

Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH

JAN 24, 2019
Da Volterra Announces Enrollment of First Patients in SHIELD, a Phase 2 Clinical Trial with DAV132, a Novel Microbiota Protective Therapy
Clinical & Manufacturing

Da Volterra Announces Enrollment of First Patients in SHIELD, a Phase 2 Clinical Trial with DAV132, a Novel Microbiota Protective Therapy

JAN 6, 2019